Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer
by on Friday, August 10th, 2012 | No Comments
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Capecitabine and aflibercept
Sponsors: Duke University; Duke University; Sanofi-Aventis
Not yet recruiting – verified August 2012
View post: Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer